Advertisement
Advertisement
U.S. markets close in 45 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Canopus BioPharma Incorporated (CBIA)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.04500.0000 (0.00%)
As of 12:43PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0450
Open0.0450
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0450 - 0.0450
52 Week Range0.0300 - 0.5100
Volume100
Avg. Volume1,385
Market Cap418,500
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for CBIA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • CANOPUS BIOPHARMA INC
    Analyst Report: Lilly(Eli) & CoEli Lilly, based in Indianapolis, develops and manufactures therapies to treat pain, diabetes, cancer, and neurodegenerative diseases. The shares are a component of the S&P 500.
    Rating
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more
  • We're sorry we weren't able to find anything about this topic.

Advertisement
Advertisement